Vicarious Surgical Q3 loss $0.10 GAAP, delays system build to Fall 2024, De Novo to 2026

Vicarious Surgical Inc.

2023-Q3 EPS reported -$0.43

GAAP net loss $15.7M ($0.10/sh); adjusted net loss $20.4M ($0.12/sh).
Cash $110M (incl. $47M equity proceeds); Q3 cash burn $16.8M. FY23 cash burn guidance $60-65M; FY24 preliminary $40-55M.
Version 1.0 system build delayed to Fall 2024; De Novo submission now expected early-mid 2026 due to market and integration challenges.
Operating expenses $21.4M, down 4% YoY; R&D $13.0M, G&A $6.9M, S&M $1.4M.

item 2.02 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.85

Vicarious Surgical Inc. reported the quarter ended September 30, 2023 results: net income GAAP net loss for the third quarter was $15.7 million, equating to a net loss per share of $0.10, EPS net loss per share of $0.10. Guidance reaffirmed.

Period: the quarter ended September 30, 2023
Net income: GAAP net loss for the third quarter was $15.7 million, equating to a net loss per share of $0.10
EPS: net loss per share of $0.10
Guidance: reaffirmed
Result: reported results

Exact text from the filing

Vicarious Surgical Reports Third Quarter 2023 Financial Results

View on SEC.gov

Browse all earnings releases →

Vicarious Surgical Inc. filing history →

Source: SEC EDGAR

accession 0001213900-23-086117

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.